Related Experiment Videos
Overcoming treatment resistance in depression
1Department of Psychiatry, Yale University School of Medicine, New Haven, Conn 06520-8037, USA.
The Journal of Clinical Psychiatry
|October 31, 1998
Summary
Treatment-resistant depression requires specific management strategies. This review covers augmentation and switching antidepressants, discussing their pros and cons for mental health professionals.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Treatment-resistant depression (TRD) presents a significant clinical challenge.
- Many patients do not achieve remission with initial antidepressant therapy.
- Effective management of TRD is crucial for patient outcomes.
Purpose of the Study:
- To review current strategies for managing treatment-resistant depression.
- To discuss augmentation and antidepressant switching as therapeutic options.
- To analyze the advantages and disadvantages of these TRD management approaches.
Main Methods:
- Literature review of studies on treatment-resistant depression.
- Analysis of augmentation strategies in antidepressant therapy.
- Evaluation of antidepressant switching protocols.
- Discussion of clinical evidence and expert opinion.
Main Results:
- Augmentation strategies involve adding another medication to the current antidepressant.
- Switching antidepressants involves discontinuing the current medication and starting a new one.
- Both strategies have potential benefits and drawbacks that vary by patient.
Conclusions:
- Effective management of treatment-resistant depression often requires a systematic approach.
- Augmentation and switching are key strategies to consider when initial treatment fails.
- Careful consideration of individual patient factors is essential for optimizing TRD treatment.